Legal status by country
Is Therapeutic Plasma Exchange legal?
Written by Aaron CuhaReviewed Sep 2026
How Therapeutic Plasma Exchange is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Not approved | Not approved | Not approved |
| Classification | Approved medical procedure; not approved for ageing indications | Established medical procedure; not licensed for ageing indications | Established medical procedure; not registered for ageing indications | Established medical procedure; not approved for ageing indications |
| Note | None recorded | None recorded | None recorded | None recorded |
US FDA status: Therapeutic plasma exchange is an established medical procedure performed with cleared apheresis devices and has recognised indications in neurological, haematological and renal disease. It is not approved for ageing, biological age reduction or Alzheimer disease anywhere.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.